- $31.68bn
- $36.74bn
- $21.38bn
- 89
- 34
- 92
- 82
Annual income statement for CDW, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 18,032 | 18,468 | 20,821 | 23,749 | 21,376 |
| Cost of Revenue | |||||
| Gross Profit | 3,040 | 3,210 | 3,569 | 4,687 | 4,652 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 16,899 | 17,288 | 19,366 | 22,014 | 19,695 |
| Operating Profit | 1,134 | 1,179 | 1,455 | 1,735 | 1,681 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 950 | 1,002 | 1,298 | 1,488 | 1,450 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 737 | 789 | 989 | 1,115 | 1,104 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 737 | 789 | 989 | 1,115 | 1,104 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 737 | 789 | 989 | 1,115 | 1,104 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.03 | 5.58 | 7.29 | 8.53 | 9.21 |
| Dividends per Share |